--- title: "Oversold Conditions For Mediwound (MDWD)" type: "News" locale: "en" url: "https://longbridge.com/en/news/287819163.md" description: "Mediwound Ltd. (MDWD) shares have entered oversold territory with a Relative Strength Index (RSI) of 26.3, indicating potential buying opportunities as heavy selling may be exhausting. The stock traded as low as $14.14, with a 52-week range of $14.14 to $22.505. In contrast, the S&P 500 ETF (SPY) has an RSI of 74.2." datetime: "2026-05-27T20:40:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287819163.md) - [en](https://longbridge.com/en/news/287819163.md) - [zh-HK](https://longbridge.com/zh-HK/news/287819163.md) generator: "portal-rs" --- # Oversold Conditions For Mediwound (MDWD) Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In trading on Wednesday, shares of Mediwound Ltd. (Symbol: MDWD) entered into oversold territory, hitting an RSI reading of 26.3, after changing hands as low as $14.14 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 74.2. A bullish investor could look at MDWD's 26.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of MDWD shares: Looking at the chart above, MDWD's low point in its 52 week range is $14.14 per share, with $22.505 as the 52 week high point — that compares with a last trade of $14.33. Find out what 9 other oversold stocks you need to know about » ### Further MDWD Research: - MDWD Average Annual Return - Top Ten Hedge Funds Holding MDWD - Stocks Insiders Are Buying But Hedge Funds Are Selling The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. ### Related Stocks - [MDWD.US](https://longbridge.com/en/quote/MDWD.US.md) - [SPY.US](https://longbridge.com/en/quote/SPY.US.md) - [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md) ## Related News & Research - [New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)](https://longbridge.com/en/news/296913005.md) - [MediWound (NASDAQ:MDWD) COO Shmuel Hess Sells 3,958 Shares](https://longbridge.com/en/news/297369446.md) - [MediWound COO, Chief Commercial Officer Shmuel Hess sells 5,823 shares for $75,097.55](https://longbridge.com/en/news/297364072.md) - [This 2 ETF Portfolio Historically Outperforms the S&P 500 With Less Volatility](https://longbridge.com/en/news/297428180.md) - [Top 3 Energy Stocks That Could Lead To Your Biggest Gains In Q3](https://longbridge.com/en/news/297635448.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**